Maria-Rocio Meini

Dr. Maria-Rocio Meini

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

20 August 2015 in FEBS Letters
Verified
Journal Article
Closed access
MMMaria-Rocio Meini
Maria-Rocio Meini
LLLeticia Irene Llarrull
Leticia Irene Llarrull
AVAlejandro Vila
Alejandro Vila

1 July 2014 in Antibiotics
Verified
Journal Article
Open access
PDF file
MMMaria-Rocio Meini
Maria-Rocio Meini
LLLeticia Irene Llarrull
Leticia Irene Llarrull
AVAlejandro Vila
Alejandro Vila
The production of β-lactamase enzymes is one of the most distributed resistance mechanisms towards β-lactam antibiotics. Metallo-β-lactamases constitute a worrisome group of these kinds of enzymes, since they present a broad spectrum profile, being able to hydrolyze not only penicillins, but also the latest generation of cephalosporins and carbapenems, which constitute at present the last resource antibiotics. The VIM, IMP, and NDM enzymes comprise the main groups of clinically relevant metallo-β-lactamases. Here we present an update of the features of the natural variants that have emerged and of the ones that have been engineered in the laboratory, in an effort to find sequence and structural determinants of substrate preferences. This knowledge is of upmost importance in novel drug design efforts. We also discuss the advances in knowledge achieved by means of in vitro directed evolution experiments, and the potential of this approach to predict natural evolution of metallo-β-lactamases.The production of β-lactamase enzymes is one of the most distributed resistance mechanisms towards β-lactam antibiotics. Metallo-β-lactamases constitute a worrisome group of these kinds of enzymes, since they present a broad spectrum profile, being able to hydrolyze not only penicillins, but also the latest generation of cephalosporins and carbapenems, which constitute at present the last resource antibiotics. The VIM, IMP, and NDM enzymes comprise the main groups of clinically relevant metallo-β-lactamases. Here we present an update of the features of the natural variants that have emerged and of the ones that have been engineered in the laboratory, in an effort to find sequence and structural determinants of substrate preferences. This knowledge is of upmost importance in novel drug design efforts. We also discuss the advances in knowledge achieved by means of in vitro directed evolution experiments, and the potential of this approach to predict natural evolution of metallo-β-lactamases.

12 March 2015 in Molecular Biology and Evolution
Verified
Journal Article
Open access
PDF file
MMMaria-Rocio Meini
Maria-Rocio Meini
PTPablo E. Tomatis
Pablo E. Tomatis
DWDaniel M. Weinreich
Daniel M. Weinreich
AVAlejandro Vila
Alejandro Vila
Understanding the driving forces behind protein evolution requires the ability to correlate the molecular impact of mutations with organismal fitness. To address this issue, we employ here metallo-β-lactamases as a model system, which are Zn(II) dependent enzymes that mediate antibiotic resistance. We present a study of all the possible evolutionary pathways leading to a metallo-β-lactamase variant optimized by directed evolution. By studying the activity, stability and Zn(II) binding capabilities of all mutants in the preferred evolutionary pathways, we show that this local fitness landscape is strongly conditioned by epistatic interactions arising from the pleiotropic effect of mutations in the different molecular features of the enzyme. Activity and stability assays in purified enzymes do not provide explanatory power. Instead, measurement of these molecular features in an environment resembling the native one provides an accurate description of the observed antibiotic resistance profile. We report that optimization of Zn(II) binding abilities of metallo-β-lactamases during evolution is more critical than stabilization of the protein to enhance fitness. A global analysis of these parameters allows us to connect genotype with fitness based on quantitative biochemical and biophysical parameters.

24 June 2012 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
JGJavier M González
Javier M González
MMMaria-Rocio Meini
Maria-Rocio Meini
PTPablo E Tomatis
Pablo E Tomatis
FMFrancisco Javier Medrano
Francisco Javier Medrano
JCJulia Alejandra Cricco
Julia Alejandra Cricco
AVAlejandro Vila
Alejandro Vila
Bacterial resistance is propagated in part by metallo-β-lactamases, which hydrolyze and inactivate β-lactam antibiotics. An unusual cysteine residue in the active site is now shown to be critical for retaining the second metal ion, and thus enzyme activity, at low zinc concentrations. A number of multiresistant bacterial pathogens inactivate antibiotics by producing Zn(II)-dependent β-lactamases. We show that metal uptake leading to an active dinuclear enzyme in the periplasmic space of Gram-negative bacteria is ensured by a cysteine residue, an unusual metal ligand in oxidizing environments. Kinetic, structural and affinity data show that such Zn(II)-cysteine interaction is an adaptive trait that tunes the metal binding affinity, thus enabling antibiotic resistance at restrictive Zn(II) concentrations.

1 February 2021 in Food Chemistry
Verified
Journal Article
Closed access
ICIgnacio Cabezudo
Ignacio Cabezudo
MMMaria-Rocio Meini
Maria-Rocio Meini
CPCarla C. Di Ponte
Carla C. Di Ponte
NMNatasha Melnichuk
Natasha Melnichuk
CBCarlos E. Boschetti
Carlos E. Boschetti
DRDiana Romanini
Diana Romanini